03/12/2015 - 1:53pm

CVS Health’s chief medical officer Troyen Brennan said in an interview with Reuters that the entry of copycat biotech drugs could cut prices of expensive medications by 40% to 50%.

03/11/2015 - 1:33pm

A new MIT study published Wednesday suggests that a more powerful H1N1 influenza strain may be making its way through India. 

03/11/2015 - 12:50pm

Mylan expanded its portfolio of generic products with the U.S. launch of buprenorphine hydrochloride sublingual tablets in 2-mg and 8-mg strengths, the generic version of Subutex from Reckitt Benckiser.

03/11/2015 - 12:40pm

Mylan on Wednesday announced the launch of disulfiram tablets USP in dosage strengths of 250 mg and 500 mg.

03/10/2015 - 3:52pm

Teva Pharmaceuticals will sell its Sellersville, Penn., facility to G&W Labs. According to Teva, the move supports its mission of streamlining operations by reducing excess manufacturing capacity.

03/10/2015 - 3:38pm

ANI Pharmaceuticals acquired the approved abbreviated new drug application for flecainide acetate tablets USP in 50-mg, 100-mg and 150-mg dosage strengths.

03/10/2015 - 2:46pm

The Food and Drug Administration recently published bio-equivalence guidance documents. 

03/10/2015 - 1:19pm

Actavis expanded its portfolio of topicals with the launch of a generic corticosteroid.

03/10/2015 - 10:55am

Impax Labs completed its acquisition of Tower Holdings (which includes operating subsidiaries CorePharma and Amedra Pharmaceuticals), and Lineage Therapeutics. Impax also announced that it would reshape both the operating and reporting structure of its two divisions.